Company Filing History:
Years Active: 2023
Title: Vincent Moultion: Innovator in Cancer Classification and Prognosis
Introduction
Vincent Moultion is a notable inventor based in Norfolk, GB. He has made significant contributions to the field of cancer research, particularly in the classification and prognosis of prostate cancers. His innovative work aims to improve patient outcomes by identifying aggressive forms of cancer that require treatment.
Latest Patents
Vincent Moultion holds a patent for his invention titled "Classification and prognosis of cancer." This invention focuses on the classification of cancers, especially prostate cancers, using patient samples. The methods provided by this invention help in identifying potentially aggressive prostate cancers, allowing for better treatment decisions. The invention is particularly useful in distinguishing between cancers that will become aggressive and those that will remain indolent. This innovation is crucial for identifying patients with a poor prognosis. The specific type of cancer identified by this invention is referred to as DESNT cancer. Additionally, the invention includes biomarker panels that are beneficial for cancer diagnosis and prognosis.
Career Highlights
Vincent Moultion is affiliated with the University of East Anglia, where he continues to advance his research in cancer classification. His work has garnered attention for its potential impact on patient care and treatment strategies.
Collaborations
Vincent has collaborated with notable colleagues, including Bogdan-Alexandru Luca and Daniel Simon Brewer. Their combined expertise contributes to the ongoing research and development in the field of cancer prognosis.
Conclusion
Vincent Moultion's innovative work in cancer classification and prognosis represents a significant advancement in medical research. His contributions have the potential to improve the lives of many patients facing prostate cancer.